Copyright: ©Author(s) 2026.
World J Diabetes. Nov 15, 2026; 17(11): 124628
Published online Nov 15, 2026. doi: 10.4239/wjd.124628
Published online Nov 15, 2026. doi: 10.4239/wjd.124628
Figure 4 Correlation between oncostatin M levels and multiple clinical indicators in 87 patients with diabetes mellitus-community-acquired pneumonia.
A: Confusion, uremia, respiratory rate, blood pressure, and age ≥ 65 years score; B: Pneumonia severity index score; C: White blood cell; D: Neutrophil; E: Neutrophil-to-lymphocyte ratio; F: Procalcitonin; G: Interleukin-6; H: Interleukin-8. OSM: Oncostatin M; CURB-65: Confusion, uremia, respiratory rate, blood pressure, and age ≥ 65 years; PSI: Pneumonia severity index; WBC: White blood cell; NEU: Neutrophil; NLR: Neutrophil-to-lymphocyte ratio; PCT: Procalcitonin; IL-6: Interleukin-6; IL-8: Interleukin-8.
- Citation: Sun Y, Li Q, Wang H, Gu MH, Teng PK, Zhang XY, Han XD, Liu XD. Association of serum oncostatin M with disease severity and mortality in community-acquired pneumonia with diabetes mellitus. World J Diabetes 2026; 17(11): 124628
- URL: https://www.wjgnet.com/1948-9358/full/v17/i11/124628.htm
- DOI: https://dx.doi.org/10.4239/wjd.124628